Cargando…
A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major depressive disorder in Japan
The aim of this study was to assess antidepressant efficacy and safety of venlafaxine extended release in Japanese patients with major depressive disorder (MDD). We carried out a double-blinded, placebo-controlled, randomized study using fixed (75 mg/day) and flexible (75–225 mg/day, most patients a...
Autores principales: | Higuchi, Teruhiko, Kamijima, Kunitoshi, Nakagome, Kazuyuki, Itamura, Rio, Asami, Yuko, Kuribayashi, Kazuhiko, Imaeda, Takayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams And Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667751/ https://www.ncbi.nlm.nih.gov/pubmed/26513202 http://dx.doi.org/10.1097/YIC.0000000000000105 |
Ejemplares similares
-
Factors impacting the efficacy of venlafaxine extended release 75–225 mg/day in patients with major depressive disorder: exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan
por: Watanabe, Yoshinori, et al.
Publicado: (2018) -
Venlafaxine extended release (XR) in the treatment of panic disorder
por: Kjernisted, Kevin, et al.
Publicado: (2007) -
VENLAFAXINE-INDUCED MANIA
por: Jagadheesan, K., et al.
Publicado: (2001) -
Venlafaxine besylate monohydrate
por: Corvalan, Carolina H., et al.
Publicado: (2013) -
Kleptomania Induced by Venlafaxine
por: Sakurada, Kumi, et al.
Publicado: (2021)